摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-tert-butoxycarbonyl-2-exo-(2’-fluoro-3‘-(4-benzenesulfonamide)-5‘-pyridinyl)-7-azabicyclo[2.2.1]heptane

中文名称
——
中文别名
——
英文名称
7-tert-butoxycarbonyl-2-exo-(2’-fluoro-3‘-(4-benzenesulfonamide)-5‘-pyridinyl)-7-azabicyclo[2.2.1]heptane
英文别名
7-(tert-butoxycarbonyl)-2-exo-[2-fluoro-3-(4-sulfamoylphenyl)-5-pyridinyl]-7-azabicyclo[2.2.1]heptane
7-tert-butoxycarbonyl-2-exo-(2’-fluoro-3‘-(4-benzenesulfonamide)-5‘-pyridinyl)-7-azabicyclo[2.2.1]heptane化学式
CAS
——
化学式
C22H26FN3O4S
mdl
——
分子量
447.531
InChiKey
BPQILBDBUKKUOK-AYBZRNKSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.79
  • 重原子数:
    31.0
  • 可旋转键数:
    3.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    102.59
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] NICOTINIC RECEPTOR COMPOUNDS<br/>[FR] COMPOSÉS RÉCEPTEURS NICOTINIQUES
    申请人:RES TRIANGLE INST
    公开号:WO2013101802A1
    公开(公告)日:2013-07-04
    Compounds and compositions for promoting smoking cessation or descreasing tobacco use or nicotine addiction are provided. The compounds are 2'-fluoro-3'-(substituted phenyl) deschloroepibatidine analogs. The compounds have been found to modulate neuronal nicotine acetylcholine receptors and are useful in methods for the treatment of conditions or disorders influenced by the modulation of neuronal nicotinic acetylcholine receptors.
    提供用于促进戒烟或减少吸烟或尼古丁成瘾的化合物和组合物。这些化合物是2'-氟-3'-(取代苯基)去氯表皮胆碱类似物。已发现这些化合物能调节神经尼古丁乙酰胆碱受体,并可用于治疗受神经尼古丁乙酰胆碱受体调节影响的疾病或疾病的方法。
  • Synthesis and Nicotinic Acetylcholine Receptor in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-3′-(substituted phenyl)deschloroepibatidine Analogues of 2′-Fluoro-3′-(4-nitrophenyl)deschloroepibatidine
    作者:Pauline Ondachi、Ana Castro、Charles W. Luetje、M. Imad Damaj、S. Wayne Mascarella、Hernán A. Navarro、F. Ivy Carroll
    DOI:10.1021/jm300575y
    日期:2012.7.26
    Herein, we report the synthesis and nicotinic acetylcholine receptor (nAChR) in vitro and in vivo pharmacological properties of 2′-fluoro-3′-(substituted phenyl)deschloroepibatidines 5b–g, analogues of 3′-(4-nitrophenyl) compound 5a. All compounds had high affinity for α4β2-nAChR and low affinity for α7-nAChR. Initial electrophysiological studies showed that all analogues were antagonists at α4β2-
    在此,我们报告了 2'-氟-3'-(取代苯基)去氯表巴替丁5b – g的合成和烟碱乙酰胆碱受体 (nAChR) 的体外和体内药理学特性,3'-(4-硝基苯基) 化合物5a 的类似物. 所有化合物对 α4β2-nAChR 具有高亲和力,对 α7-nAChR 具有低亲和力。最初的电生理学研究表明,所有类似物都是 α4β2-、α3β4- 和 α7-nAChR 的拮抗剂。4-氨基甲酰基苯基类似物5g对 α4β2-nAChR 的选择性高于 α3β4- 和 α7-nAChR。在甩尾试验中,所有类似物都是尼古丁诱导的镇痛作用的拮抗剂。使用乙酰胆碱结合蛋白的 X 射线晶体结构的激动剂结合形式进行的分子建模对接研究表明,表巴替丁、伐尼克兰和5a - g 有几种不同的结合模式。特别是,这些对接模拟提出了一种独特的5g绑定模式。5g对 α4β2-nAChR的高结合亲和力、体外功效和选择性及其 nAChR 功能拮抗剂特性表明5g
查看更多

同类化合物

2-(2'-氟-5'-吡啶基)-7-氮杂双环(2.2.1)庚烷 (±)-三色素蛙素 (1S,4R,6S)-6-(6-氯吡啶-3-基)-7-氮杂双环[2.2.1]庚烷 (1R,2R,4S)-2-(6-甲氧基吡啶-3-基)-7-氮杂双环[2.2.1]庚烷 2-fluoro-3-(2'-amino-4'-pyridinyl)deschlorocpibatidine 7-tert-butoxycarbonyl-2-exo-[2'-amino-3'-(pyridin-4-yl)-5'-pyridinyl]-7-azabicyelo[2.2.1]heptane (+/-)-N-Boc-epibatidine 7-carbethoxy-2β-(2-chloro-5-pyridinyl)-3α-carbomethoxy-7-azabicyclo<2.2.1>heptane 7-tert-butoxycarbonyl-2-exo-(2’-fluoro-3‘-(4-benzenesulfonamide)-5‘-pyridinyl)-7-azabicyclo[2.2.1]heptane 7-tert-butoxycarbonyl-2-exo-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptan-3-one 7-tert-butoxycarbonyl-2-endo-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptan-3-one Tert-butyl 2-(6-amino-5-bromopyridin-3-yl)-7-azabicyclo[2.2.1]heptane-7-carboxylate (+/-)-epibatidine dihydrochloride (+)-Epibatidine dihydrochloride 7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane (1R,2R,4S)-2-(6-Methoxy-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane-7-carboxylic acid tert-butyl ester 2-(6-Chloro-5-phenyl-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane (2S)-2-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane Dtxcid1028865 4-((1R,2R,4S)-5-7-Aza-bicyclo[2.2.1]hept-2-yl-2-fluoro-pyridin-3-yl)-benzonitrile [(1R,2R,3S,4S)-7-Benzyl-3-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]hept-2-yl]-((1S,5R,7R)-10,10-dimethyl-3,3-dioxo-3λ6-thia-4-aza-tricyclo[5.2.1.01,5]dec-4-yl)-methanone (-)-epibatidine exo-2-(2'-fluoro-5'-pyridyl)-7-azabicyclo<2.2.1>heptane (1S,2S,4S)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4S)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (+/-)-Epibatidine (1S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-Bromopyridin-3-yl)-7-methyl-7-azabicyclo[2.2.1]heptane 2-(6-Chloro-2-methylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane;hydrochloride 6'-Methylepibatidine 2-(6-(18F)fluoranyl-5-phenylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4S)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4R)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2S,4R)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-chloropyridin-3-yl)-7-(111C)methyl-7-azabicyclo[2.2.1]heptane (2R)-2-(6-(18F)fluoranylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (-)-Epibatidine dihydrochloride 5-(7-Azabicyclo[2.2.1]heptan-2-yl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one 3-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptan-2-one 5-[[(2R)-azetidin-2-yl]methoxy]-2-chloropyridine;(1S,2S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(18F)fluoranylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(125I)iodanylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(123I)iodanylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (3R,4S)-3-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane epibatidine